DXCM Dexcom Inc

DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.

$561.95  -9.06 (-1.59%)
As of 11/30/2021 15:59:56 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  04/14/2005
Outstanding shares:  96,922,034
Average volume:  626,964
Market cap:   $57,373,967,247
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    252131107
ISIN:        US2521311074
Sedol:      B0796X4

---

Valuation   (See tab for details)

---

PE ratio:   104.56
PB ratio:   25.90
PS ratio:   24.74
Return on equity:   24.78%
Net income %:   22.82%